Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1103-1108

  Peterson, Jerry A ^a   Blank, Edward W ^a   Ceriani, Roberto L ^a  

^a Cancer Research Fund of Contra Costa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MC5; MUCIN; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RADIATION DOSE FRACTIONATION; RADIOIMMUNOTHERAPY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CA-15-3 ANTIGEN; ESTROGENS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 0030888265     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 131I-labeled monoclonal antibodies prepared against the human milk fat globule. Cancer Res., 48: 4664-4672, 1988.
2. Ceriani, R. L., Blank, E. W., and Peterson, J. A. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components. Cancer Res., 47: 532-540, 1987.
3. Ceriani, R. L., Blank, E. W., Couto, J. R., and Peterson, J. A. Biological activity of two humanized antibodies against two different breast cancer antigens and comparison to their murine original forms. Cancer Res., 55(Suppl.): 5852s-5856s, 1995.
4. Peterson, J. A., Couto, J. R., and Ceriani, R. L. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Cancer Res., 55(Suppl.): 5947s-5951s, 1995.
5. Blank, E. W., Pant, K. D., Chan, C. M., Peterson, J. A., and Ceriani, R. L. A novel anti-breast epithelial mucin MAb (BrE-3). Characterization and experimental biodis-tribution and immunotherapy. Cancer J., 5: 38-44, 1992.
6. Santos, O., Pant, K. D., Blank, E. W., and Ceriani, R. L. 5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice. J. Nucl. Med., 33: 1530-1534, 1992.
7. Kramer, E. L., DeNardo, S. J., Liebes, L., Kroger, L. A., Noz, M. E. G., Mizrachi, H., Salako, Q. A., Furmanski, P., Glenn, S. D., DeNardo, G. L., and Ceriani, R. L. Radioimmunolocalization of metastatic breast carcinoma using Indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: Phase 1 study. J. Nucl. Med., 34: 1067-1074, 1993.
8. DeNardo, S. J., Kramer, E. L., Richman, C. M., Salako, Q. A., Perez, E. A., O'Grady, L. F., Rippon, M. B., Glenn, S. D., Butchko, G., Couto, J. R., Ceriani, R. L., and DeNardo, G. L. Radioimmunotherapy of breast cancer with Y-90/In-111 BrE-3: current clinical results and therapeutic potential. J. Nucl. Med., 34: 53P, 1993.
9. 90Y MX-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a Phase I trial. Cancer Res., 55(Suppl.): 5921s-5924s, 1995.
10. Schneider, J., Bak, M., Efferth, T., Kaufmann, M., Mattern, J., and Volm, M. P-glycoprotein expression in treated and untreated human breast cancer. Br. J. Cancer, 60: 815-818, 1989.
11. Hull, D. F., Clark, G. M., Osborne, C. K., Chamness, G. C., Knight, W. A., and McGuire, W. L. Multiple estrogen receptor assays in human breast cancer. Cancer Res., 43: 413-416, 1983.
12. Gross, G. E., Clark, G. M., Chamness, G. C., and McGuire, W. L. Multiple progesterone receptor assays in human breast cancer. Cancer Res., 44: 836-840, 1984.
13. 90Y-anti-CEA monoclonal antibody. Antib. Immunoconjug. Radiopharm., 3: 50, 1990.
14. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milik, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. D., and Wahl, R. L. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol., 14: 1974-1978, 1996.
15. Vervoordeldonk, S. F., Balkenende, A. Y., van den Berg, H., von dem Borne, A. E., van der School, C. E., Van Leeuwen, E. J., and Slaper-Cortenbach, I. C. Degradation of radioiodinated B-cell monoclonal antibodies: inhibition via a FCγ-receptor-II-mediated mechanism and by drugs. Cancer Immunol. Immunother., 42: 24-30, 1996.
16. Stashenko, P., Nadler, L. M., Hardy, R., and Schlossman, S. F. Characterization of a human B lymphocyte-specific antigen. J. Immunol., 725: 1678-1685, 1980.
17. Peterson, J. A., Zava, D. T., Duwe, A. K., Blank, E. W., Battifora, H., and Ceriani, R. L. Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule. Hybridoma, 9: 221-235, 1990.
18. Ceriani, R. L., Peterson, J. A., Lee, J. Y., Moncada, R., and Blank, E. W. Characterization of cell surface antigens of human mammary epithelial cells with monoclonal antibodies prepared against human milk fat globule. Somatic Cell Genet., 9: 415-427, 1983.
19. Peterson, J. A., Larocca, D., Walkup, G., Amiya, R., and Ceriani, R. L. Molecular analysis of epitope heterogeneity of the breast mucin. In: R. L. Ceriani (ed.), Breast Epithelial Antigens: Molecular Biology to Clinical Applications, pp. 55-68. New York: Plenum Publications, 1991.
20. 131I-labeled human growth hormone of high specific radioactivity. Biochem. J., 89: 114-123, 1963.
21. Ceriani, R. L., Peterson, J. A., Blank, E. W., Chan, C. M., and Cailleau, R. Development and characterization of breast carcinoma cell lines as in vitro and in vivo models for breast cancer diagnosis and therapy. In Vitro Cell. Dev. Biol., 28A: 397-402, 1992.
22. Peterson, J. A., Blank, E. W., Zoellner, C., Enloe, S., Walkup, G., and Ceriani, R. L. Cell heterogeneity and complexity of breast epithelial surface antigens expression and MoAb therapy. In: R. L. Ceriani (ed.), Breast Cancer Immunodiagnosis and Immunotherapy, pp. 95-104. New York: R. Plenum Publishing, 1989.
23. Kearney, J. F., and Lawton, A. R. B lymphocyte differentiation induced by lipopolysaccharide. J. Immunol., 775: 671-676, 1975.
24. Sheldon, K., Marks, A., and Baumal, R. Characterization of binding of four monoclonal antibodies to the human ovarian adenocarcinoma cell line HEY. Biochem. Cell Biol., 65: 423-428, 1987.
25. Ceriani, R. L., Chan, C. M., Baratta, F. S., Ozzello, L., DeRosa, C. M., and Habif, D. V. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast cancer prognosis. Int. J. Cancer, 51: 343-354, 1992.
26. 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies. Cancer Res., 50(Suppl.): 989s-992s, 1990.
27. 90Y-α-carcinoembryonic antigen monoclonal antibody. Cancer Res., 51: 3802-3806, 1991.
28. Sugarbaker, P. H. Role of carcinoembryonic antigen assay in the management of cancer. Adv. Immun. Cancer Ther., 1: 167-193, 1985.
29. Robertson, J. F., Ellis, I. O., Bell, J., Todd, J. H., Robins, A., Elston, C. W., and Blamey, R. W. Carcinoembryonic antigen immunocytochemistry in primary breast cancer. Cancer (Phila.), 64: 1638-1645, 1989.
30. Gion, M., Mione, R., Dittadi, R., Griggio, L., Munegato, G., Valsecchi, M., Del Maschio, O., and Bruscagnin, G. Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue. Int. J. Biol. Markers, 1: 33-38, 1991.
31. Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J. M., Pemberton, L., Lalani, E. N., and Wilson, D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem., 265: 15286-15293, 1990.
32. Burchell, J. M., Taylor-Papadimitriou, J., Boshell, M., Gendler, S. J., and Duhig, T. A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int. J. Cancer, 44: 691-696, 1989.
33. Barnd, D. L., Lan, M. S., Metzgar, R. S., and Finn, O. J. Specific, major histocompatiblity complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 86: 7159-7163, 1989.
34. 131I-Lym-l. Cancer Res., 50(Suppl.): 1014s-1016s, 1990.
35. Couto, J., Blank, E. W., Peterson, J. A., and Ceriani, R. L. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody. Hybridoma, 12: 15-23, 1993.
36. Couto, J. R., Blank, E. W., Peterson, J. A., Kiwan, R., Padlan, E. A., and Ceriani, R. L. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3. In: R. L. Ceriani (ed.), Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment, pp. 55-60. New York: Plenum Publishing Corp., 1993.